First investment round · Biotech
eubiOmic Health raises €200,000 for commercial preparation
Nazarí Ventures and private investors back the company’s first capital increase.
The funding supports manufacturing preparation, an applicator and the documentation needed to bring the product to market. A pilot batch and a study of user experience and uptake are planned for 2027.
The company is working toward a Spanish launch in the second half of 2027, with pharmacy distribution and direct online subscriptions forming its proposed sales model.
Use of funds
Industrialise formulation and applicator
Complete regulatory documentation
Produce pilot batch and prepare commercial launch
Funding history
First investment round · This round€200K